Liberisan (Cytisinicline)

Cytisinicline acts as a partial agonist at α4β2 nicotinic acetylcholine receptors in the brain. This modest stimulation eases withdrawal while blocking nicotine’s reinforcing effects, thereby decreasing cravings and helping the user maintain abstinence from tobacco.

The specific dose of Liberisan is determined by the prescribing healthcare professional based on the patient’s medical history, smoking habits, and response to therapy. Dosage instructions are individualized and should be followed as directed by the prescriber.

Safety data for Cytisinicline in pregnancy and lactation are limited. Healthcare providers should weigh potential benefits against possible risks before prescribing Liberisan to pregnant or nursing individuals, and discuss alternative cessation strategies when appropriate.

To request Liberisan, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Unlike nicotine replacement therapies that deliver nicotine, Liberisan’s Cytisinicline targets nicotinic receptors directly as a partial agonist, offering craving reduction without nicotine exposure. Compared with full agonists such as varenicline, it may present a different side‑effect profile, but clinical choice depends on individual patient factors and physician judgment.

Liberisan should be stored at room temperature, below 25 °C, in its original container. Keep the product away from moisture, direct sunlight, and extreme temperatures to maintain stability and potency throughout its shelf life.

Liberisan is taken orally as directed by a healthcare professional. The tablet (or capsule) is swallowed with water, typically at regular intervals prescribed by the clinician, and should be used as part of a comprehensive smoking‑cessation program.

Serious risks, though rare, include severe allergic reactions such as anaphylaxis and significant mood changes like depression or anxiety. Patients should seek immediate medical attention if they experience symptoms such as rash, swelling, breathing difficulty, or sudden changes in mood.

Liberisan is contraindicated in individuals with known hypersensitivity to Cytisinicline or any excipients, and should be used with caution in patients with uncontrolled cardiovascular disease, severe psychiatric disorders, or those taking interacting medications listed under major interactions.